The Cooper Companies operates through two segments: CooperVision, a global manufacturer of soft contact lenses (single-use, two-week, and monthly) addressing astigmatism, presbyopia, and myopia, including the FDA-approved MiSight 1 day myopia management lens for children; and CooperSurgical, which provides more than 600 products and services spanning gynecological and obstetric medical devices, contraception, and fertility solutions including IVF support, cryopreservation, egg and sperm donation, and genomic testing services.
Cooper sells products in over 130 countries, serving three CooperVision geographic regions (Americas, EMEA, Asia Pacific) and CooperSurgical customers in medical offices, ambulatory surgery centers, hospitals, and fertility clinics. Manufacturing and distribution facilities are located in Belgium, Costa Rica, Hungary, Puerto Rico, the Netherlands, the United Kingdom, and the United States.
US 50% · Europe 31% · Rest Of The World 19%
geographic · FY2025 (ended Oct 2025) · share of tagged segment revenue (10-K XBRL, as filed)
